Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Co-PSMA: 64Cu-SAR-bisPSMA vs 68Ga PSMA-11 PET/CT in Prostate Cancer Recurrence
NCT06907641Phase 2Completed
- Sponsor
- St Vincent's Hospital
- Start
- Nov 2024
- Primary completion
- Sep 2025
- Modality
- Peptide-Drug Conjugates
- Countries
- 1
01
Overview
A Phase 2 trial of 64Cu-SAR-bisPSMA in prostate cancer (PCa), sponsored by St Vincent's Hospital. Started Nov 2024; status: completed.
02
Drugs
64Cu-SAR-bisPSMA
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT06907641.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06907641.